Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma
Sponsor: Carol Davila University of Medicine and Pharmacy
Summary
Several pancreatic neoplastic cystic lesions, such as IPMN (intrapapilary mucinous neoplasia), cystic neuroendocrine tumors (NET) and mucinous neoplasms, present a carcinogenetic risk, though it is yet unknown if this risk is increased in patients with pancreatic steatosis (PS). The primary objective of the study is to determine de prevalence of pancreatic steatosis in pancreatic neoplastic cysts and if pancreatic steatosis is increased in those lesions that pose a carcinogenetic risk. The secondary objective is to evaluate the prevalence of pancreatic steatosis in pancreatic adenocarcinoma.
Official title: The Emerging Issue - Pancreatic Steatosis Prevalence in Pancreatic Cystic Neoplasms and Adenocarcinoma: Insights From a Single-center Retrospective Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
66
Start Date
2019-01-01
Completion Date
2025-06-30
Last Updated
2025-03-10
Healthy Volunteers
Yes
Interventions
computerized tomography
Little is known about the prevalence of pancreatic steatosis in patients with pancreatic cystic lesions therefore this observational study aims to clarify the data.
Endosonography (EUS)
EUS can better evaluate all pancreatic cysts, therefore is mandatory in this observational study.
Locations (1)
Prof Dr Agrippa Ionescu; Clinical Emergency Hospital
Bucharest, Sector 1, Romania